Reaction Details |
| Report a problem with these data |
Target | Bromodomain-containing protein 9 |
---|
Ligand | BDBM50269686 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1707030 (CHEMBL4058263) |
---|
IC50 | 5000±n/a nM |
---|
Citation | Crawford, TD; Audia, JE; Bellon, S; Burdick, DJ; Bommi-Reddy, A; Côté, A; Cummings, RT; Duplessis, M; Flynn, EM; Hewitt, M; Huang, HR; Jayaram, H; Jiang, Y; Joshi, S; Kiefer, JR; Murray, J; Nasveschuk, CG; Neiss, A; Pardo, E; Romero, FA; Sandy, P; Sims, RJ; Tang, Y; Taylor, AM; Tsui, V; Wang, J; Wang, S; Wang, Y; Xu, Z; Zawadzke, L; Zhu, X; Albrecht, BK; Magnuson, SR; Cochran, AG GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2). ACS Med Chem Lett8:737-741 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bromodomain-containing protein 9 |
---|
Name: | Bromodomain-containing protein 9 |
Synonyms: | BRD9 | BRD9_HUMAN | Bromodomain-containing protein 9 | Rhabdomyosarcoma antigen MU-RMS-40.8 |
Type: | PROTEIN |
Mol. Mass.: | 66994.30 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_108000 |
Residue: | 597 |
Sequence: | MGKKHKKHKAEWRSSYEDYADKPLEKPLKLVLKVGGSEVTELSGSGHDSSYYDDRSDHER
ERHKEKKKKKKKKSEKEKHLDDEERRKRKEEKKRKREREHCDTEGEADDFDPGKKVEVEP
PPDRPVRACRTQPAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHP
MDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKQ
AALLGNEDTAVEEPVPEVVPVQVETAKKSKKPSREVISCMFEPEGNACSLTDSTAEEHVL
ALVEHAADEARDRINRFLPGGKMGYLKRNGDGSLLYSVVNTAEPDADEEETHPVDLSSLS
SKLLPGFTTLGFKDERRNKVTFLSSATTALSMQNNSVFGDLKSDEMELLYSAYGDETGVQ
CALSLQEFVKDAGSYSKKVVDDLLDQITGGDHSRTLFQLKQRRNVPMKPPDEAKVGDTLG
DSSSSVLEFMSMKSYPDVSVDISMLSSLGKVKKELDPDDSHLNLDETTKLLQDLHEAQAE
RGGSRPSSNLSSLSNASERDQHHLGSPSRLSVGEQPDVTHDPYEFLQSPEPAASAKT
|
|
|
BDBM50269686 |
---|
n/a |
---|
Name | BDBM50269686 |
Synonyms: | CHEMBL4077036 |
Type | Small organic molecule |
Emp. Form. | C21H24N6O2 |
Mol. Mass. | 392.4543 |
SMILES | CN(C1CCN(CC1)c1ccncn1)C(=O)c1cn(CC=C)c(=O)c2[nH]ccc12 |
Structure |
|